T 1156/16 (Oxycodone sustained release dosage form/EURO-CELTIQUE) of 05.07.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T115616.20170705
- Date of decision
- 5 July 2017
- Case number
- T 1156/16
- Petition for review of
- -
- Application number
- 06111805.5
- IPC class
- A61P 25/36A61K 31/485
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pharmaceutical oral dosage form comprising a combination of an opioid agonist and opioid antagonist
- Applicant name
- EURO-CELTIQUE S.A.
- Opponent name
- Hexal AG
Teva Pharmaceutical Industries Ltd.
G. L. Pharma GmbH
Actavis Group hf.
Bachelin, Martin, Dr.
KRKA, d.d., Novo mesto - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 84
- Keywords
- Claims - clarity after amendment (no)
- Catchword
- -
- Cited cases
- G 0003/14
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.